Social Media Ideas for Drug Repurposing

Old Drugs, New Tricks: How Repurposing Could Crack Cancer’s Resistance Problem

A new review in Molecular Cancer maps how approved drugs from outside oncology could be repurposed, under a strict mechanism-first framework, to dismantle the four biological progr...

A drug repurposing screen reveals dopamine signaling as a candidate therapeutic pathway for PIGA-CDG

by Miriam C. Aziz, Jennie Wilson, Clement Y. Chow PIGA-CDG is a congenital disorder of glycosylation caused by pathogenic partial loss-of-function variants in the PIGA gene. PIGA...

FDA-Approved Drug Could Be Repurposed to Relieve Osteoarthritis Pain And Protect Cartilage

(Mohammed Haneefa Nizamudeen/iStockphoto/Getty Images) A double benefit for the condition.

Repurposing ritonavir to induce proteasomal degradation of IE1 for inhibition of human cytomegalovirus replication

by Wanfeng Liu, Yu Shi, Xudong Guo, Chenyu Lou, Zhangyi Xie, Yitian Shen, Liang Zhang, Sunzhong Mao, Xiangyang Xue, Shiyu Feng Human cytomegalovirus (HCMV) is a major pathogen aff...

Disc’s once-spurned rare disease drug to get a second chance at approval

Months after the FDA rejected its treatment for a rare light-sensitivity disease, the biotech claimed success in a Phase 3 trial and now plans to re-engage regulators.

The Drive to Class GLP-1 Receptor Agonists as Geroprotective Drugs

Given a wildly successful drug, the standard pharmaceutical industry playbook is to push as hard as possible to find new uses for that drug, an effort that will tend to increase pu...

Cancer Drug Compounds Could Offer A New Way To Fight Malaria

Molecules spun off from a cancer drug may have a second job in fighting malaria. Researchers at the University of São Paulo’s School of Pharmaceutical Sciences...

Rapport’s epilepsy drug finds surprising success in bipolar trial

Despite what some analysts described as low expectations, RAP-219 narrowly hit the main goal of a mid-stage study, results that could help it tap a billion-dollar-plus market oppor...

<![CDATA[The Next Chapter in Metabolic Drug Development]]>

GLP-1 compounder issues recall for copycat Zepbound

The notice adds to growing concerns about the safety of knockoff weight loss drugs, which have remained popular despite FDA warnings and legal pressure from Eli Lilly and Novo.

Biohaven’s previously rejected rare disease drug to get fresh FDA review

U.S. regulators have accepted a new submission for Vyglxia, offering the chance at a turnaround for another rare disease medicine spurned by previous FDA leadership.

Old Antabuse Drug Turns Breast Cancer Resistance Against Itself

Chemotherapy has long been a workhorse against metastatic breast cancer, yet for most patients with estrogen receptor-positive (ER+) disease, the cancer eventually wins the evoluti...

FDA clears first generic radioligand drug; Sionna turns to layoffs

A Lutathera copycat has become the first “radioligand equivalent” cleared by regulators. Elsewhere, Novo dropped the “Nordisk” from its name and a novel RNAi drug showed early prom...

Chemical Structure, Formula, and Name Support Written Description of Pharmaceutical Genus

SADRP: A structurally aware multi-modal framework for drug response prediction

by Ren Qi, Shujia Liu, Tianhong Quan, Tianru Wu, Alexey K. Shaytan, Bin Liu Motivation Predicting drug sensitivity across diverse cancer samples is a fundamental challenge in perso...

Asthma drug shows potential to slow preterm labor in screening study

Shajila Siricilla, Ph.D., assistant professor of pediatrics, and Jennifer Herington, Ph.D., associate professor of pediatrics, led a team that systematically screened 1,191 FDA-app...

3 Common Drugs Older Adults Might Be Overusing

MONDAY, Sept. 21, 2026 — The scenario often unfolds like this: Medical researchers investigate a frequently used drug and report that it’s less effective for older patients than pr...

3 Common Drugs Older Adults Might Be Overusing

By Paula Span The scenario often unfolds like this: Medical researchers investigate a frequently used drug and report that it’s less effective for older patients than previou...

3 common drugs older adults may be overusing

The scenario often unfolds like this: Medical researchers investigate a frequently used drug and report that it’s not as effective for older patients as previously thought, or that...

<![CDATA[Regeneron and Sanofi Expand Antibody Alliance with Four New Drugs]]>

Scientists Discover an Unexpected Problem With a Cancer Drug Already in Human Trials

Earlier cancer studies may need a second look after researchers found that a drug acts mainly on an unexpected target. An experimental cancer drug already being tested in patients...

Renova Pharmaceuticals launches its first three generic products

Renova Pharmaceuticals LLC, a Fairfield-based drug company focused on bringing high-quality and affordable generic medicines to patients, announced Sept. 11 the commercial launch o...

FDA Nod for Inflammation Drug Notches Wins for Rare Disease Patients, Roivant’s Biz Strategy

Roivant Sciences subsidiary Priovant Therapeutics received FDA approval for Lisraya as a treatment for the rare inflammatory disorder dermatomyositis. Licensed from Pfizer, this on...

<![CDATA[Novo Announces Drug Discovery Collaboration with Anthropic ]]>